RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Disclosure status of children attending HIV care and treatment clinics in Burundi, Cameroon, and the Democratic Republic of Congo
Newman, J., Kamgaing, N., Nduwimana, M., Obama, M-T., Bukuru, H., Kariyo, P., Niyongabo, T., Mbaya, M., Mukumbi, H., Akam, W., Iriondo-perez, J., Atibu, J., Kiumbu, M., Azinyue, I., & Hemingway-foday, J. (2016). Disclosure status of children attending HIV care and treatment clinics in Burundi, Cameroon, and the Democratic Republic of Congo. Journal of HIV/AIDS and Social Services, 15(4), 371-379. https://doi.org/10.1080/15381501.2016.1138177
Data were obtained from 290 HIV-positive children aged 5-18 years in Burundi, Cameroon, and the Democratic Republic of Congo. We compared characteristics of those who knew their HIV serostatus (disclosed) with those that did not (undisclosed) using chi-square tests at enrollment and 6-month follow-up. We used logistic regression to determine if disclosure status was associated with antiretroviral therapy (ART) adherence. Of 144 disclosed children, the median age of disclosure was 10 years. Disclosed and undisclosed children were similar in demographic and clinical characteristics: roughly half were girls, WHO clinical stage III or IV (55% vs 56%), and the majority were receiving ART (69% vs 60%). Differences were observed in whether disclosed and undisclosed children were on cotrimoxazole prophylaxis (82% vs 51%, p < .001) and attended a support group (41% vs 14%, p < .001). We did not observe an association between disclosure and ART adherence.
